Abstract

Introduction
Management strategies for managing multimorbidity from systematic review and clinical guidelines.
Medicines management interventions
People with multimorbidity are typically affected by polypharmacy, traditionally defined as five or more medications daily, but more often involving more complex polypharmacy, i.e., 10 or more medicines. 1 Given the potential risks of adverse events associated with polypharmacy, guidelines recommend that clinicians routinely assess whether people with significant polypharmacy are benefiting from all the medicines they are prescribed, and where possible to consider deprescribing.1,6 However, the success of medicines management interventions in multimorbidity is limited, with many previous trials not targeting on higher numbers of medicines.1,2 Targeting those with more significant polypharmacy may be more effective. 7 While these interventions address the challenges that clinicians report in managing multimorbidity, 1 and often improve prescribing quality and safety, their wider impact on other clinical outcomes is less clear.
Interventions Targeting Health Behaviors
A 2020 systematic review explored the potential safety and benefits of exercise in people with multimorbidity. 3 The risk of serious adverse health outcomes (e.g., hospitalization) may be reduced for people with multimorbidity participating in an exercise intervention and younger people with multimorbidity exercising may have greater improvements in health-related quality of life. 3 Additionally, to improve adherence to exercise and other lifestyle behaviors (e.g., diet), another 2022 systematic review, 4 found that greater improvements in physical activity and weight loss were noted when specific Behavior Change Techniques were used such as Action Planning (e.g., prompt planning going for a walk at a particular time on certain days of the week) and Social Support (Practical) (e.g., ask the patient to take a partner or friend with them to their walking session). 4
Identifying and Treating Depression
There is high quality evidence that treating depression in those who have multimorbidity that involves comorbid depression improves outcomes.3-5 This highlights the value of screening for depression in patients with multimorbidity and considering depression treatment with psychological and pharmacological therapies. This approach, which priorities patient’s symptom management, is also recommended in expert clinical guidelines for multimorbidity. 6
Interventions Lacking a Significant Evidence Base
There have been multiple high-quality trials of a range of other types of interventions designed to improve multimorbidity management including case management and self-management support and these have reported mixed effects on outcomes. 2 While there is no clear evidence to support their routine implementation in clinical practice, there is a suggestion from a small number of studies that they improve the patient experience of care, which is important in the context of multimorbidity management. 2
Clinical Guidelines
Developing clinical guidelines for multimorbidity has been a challenge given the lack of clear evidence. A recent overview of existing guidelines, many of which are based on expert consensus, highlighted key consideration for clinicians. Most importantly is the need to recognize when a single condition focus is becoming unhelpful, impractical or even harmful and consider a multimorbidity approach to management.1,6 Other key management recommendations are to specifically address patient priorities and preferences and create individualized care plans with planned follow-up reviews.1,6
Conclusions
Managing multimorbidity is complex with a limited evidence-base to guide clinical practice. The certainty of the evidence is high only for treating comorbid depression and future trials may change the current evidence base. While high proportions of patients have multimorbidity, most trials of interventions for common chronic conditions exclude patients taking multiple drugs or having several chronic conditions and this needs to be addressed if we are to build an evidence base to support multimorbidity management. 1 In summary, expert guidelines and available evidence suggest that clinicians managing multimorbidity should consider the appropriateness of medicines and deprescribing; referral to exercise therapy and screening and treatment for comorbid depression.
Footnotes
Author contributions
All the authors contributed to the design and writing of the manuscript. A.B. wrote the first draft and S.M.S and S.T.S. revised the manuscript and approved the final version.
Declaration of conflicting interests
The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Funding
The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by the European Research Council (MOBILIZE; grant agreement no. 801790) (A.B. and S.T.S.) and (ESCAPE; grant agreement no. 945377) (S.T.S) the Health Research Board Collaborative Doctoral Award in Multimorbidity (HRB CDA-2013-008) (S.M.S) and a grant from Region Zealand (Exercise First) (S.T.S), The funders had no role in the design and reporting of this manuscript.
